Valiant Laboratories Ltd

Valiant Laboratories Ltd Share Price Today: Live Updates & Key Insights

Get insights on Valiant Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Valiant Laboratories Ltd Share Price Chart

Valiant Laboratories Ltd Fundamentals

Traded Volume: 81,039

Market Cap(Cr): 456

Avg Traded Price 119.19

1 Year return -23.60%

Upper Circuit 84.9

Lower Circuit 80

P/E TTM 3542.00

P/B Ratio 0.00

Traded Value(Cr) 68.08

EPS TTM 0.024

Book value 0.024

Dividend 0.00%

Valiant Laboratories Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Valiant Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Valiant Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +1.00%

1M +2.26%

3M -10.28%

1Y -23.60%

YTD -21.60%

Valiant Laboratories Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Valiant Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 40300.00

Day Before Yesterday 8914.00

1W Avg 24992.75

1M Avg 30852.71

3M Avg 58078.70

Valiant Laboratories Ltd Technical Details

Valiant Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 81

Support 2 78

Support 3 76

Pivot Point : 83

Resistance 1 86

Resistance 2 88

Resistance 3 91

Valiant Laboratories Ltd Corporate Actions

Valiant Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Valiant Laboratories Ltd’s capital allocation strategies.

All

Ex-Date 18-Jul-2025 Type R Description /share@1:4% Record Date 19-Jul-2025 Ratio 1:4

Dividends

No Dividend has been declared by VALIANTLAB

Bonus

No Bonus has been declared by VALIANTLAB

Splits

No Split has been declared by VALIANTLAB

Others

Ex-Rights Date 18-Jul-2025 Premium(Rs.) 65.00 Ratio 1:4

Valiant Laboratories Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Valiant Laboratories Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Valiant Laboratories Ltd's relative performance and valuation against major competitors.

Stock Name Albert David Ltd ₹857.15 (-1.60%) M. Cap (Cr) 4.89 1 Yr Return (%) -38.46% P/E (TTM) 77.72 PB Ratio 1.25

Stock Name Kerala Ayurveda Ltd ₹400.95 (-1.47%) M. Cap (Cr) 4.84 1 Yr Return (%) +44.90% P/E (TTM) -36.82 PB Ratio 11.78

Stock Name Amanta Healthcare Ltd ₹123.25 (+2.62%) M. Cap (Cr) 4.79 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 4.50

Stock Name Valiant Laboratories Ltd ₹84.01 (+3.51%) M. Cap (Cr) 4.56 1 Yr Return (%) -23.60% P/E (TTM) 3541.74 PB Ratio 1.44

Stock Name Influx Healthtech Ltd ₹192.90 (-2.60%) M. Cap (Cr) 4.47 1 Yr Return (%) NaN% P/E (TTM) 33.41 PB Ratio 10.85

Stock Name Medico Remedies Ltd ₹49.83 (-0.24%) M. Cap (Cr) 4.14 1 Yr Return (%) -15.24% P/E (TTM) 40.02 PB Ratio 6.62

Stock Name Bafna Pharmaceuticals Ltd ₹174.56 (+5.00%) M. Cap (Cr) 4.13 1 Yr Return (%) +117.09% P/E (TTM) 49.96 PB Ratio 4.87

Valiant Laboratories Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Valiant Laboratories Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 -21.90 Mar 2024 48.78 Mar 2023 22.96 Mar 2022 2.25 Mar 2021 9.11

PARTICULARS Investing Activities Mar 2025 24.97 Mar 2024 -182.73 Mar 2023 -21.18 Mar 2022 -12.24 Mar 2021 -16.67

PARTICULARS Financing Activities Mar 2025 -0.50 Mar 2024 135.80 Mar 2023 -1.53 Mar 2022 6.18 Mar 2021 11.43

PARTICULARS Net Cash Flow Mar 2025 2.57 Mar 2024 1.85 Mar 2023 0.24 Mar 2022 -3.81 Mar 2021 3.87

Valiant Laboratories Ltd Shareholding Pattern

This shows the ownership breakdown of Valiant Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 74.94%

Public 25.05%

Other Institutions 0.0%

FII 0.02%

Mutual Funds null%

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of `M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL). In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.

Managing Director

Santosh S. Vora

Registered office 104 Udyog Kshetra Mulund, Goregaon Link Rd Mulund West, Mumbai, Maharashtra, 400080

FAX :+91 22 49712001

Background

Incorporation Year 2021

Face Value ₹10.00

Market Lot 1

Valiant Laboratories Ltd Latest News

VIEW MORE NEWS

FAQs on Valiant Laboratories Ltd